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Abstract 
Background: To investigate effects of knockdown of epiplakin gene expression on the homeostasis of cultured cor-
neal epithelial cell line. We previously reported acceleration of corneal epithelial wound healing in an epiplakin-null 
mouse.
Methods: Gene expression of epiplakin was knockdowned by employing siRNA transfection in SV40-immortalized 
human corneal epithelial cell line. Protein expression of E-cadherin, keratin 6 and vimentin was examined by western 
blotting. Cell migration and proliferation were examined by using scratch assay and Alamar blue assay, respectively.
Results: Scratch assay and Alamar blue assay showed migration and proliferation of the cells was accelerated by 
epiplakin knockdown. siRNA-knockdown of epiplakin suppressed protein expression of E-cadherin, keratin 6 and 
vimentin.
Conclusions: Decreased expression of E-cadherin, keratin 6 and vimentin might be included in the mechanisms of 
cell migration acceleration in the absence of epiplakin. The mechanism of cell proliferation stimulation by epiplakin 
knockdown is to be investigated.
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Background
Epiplakin was one of intermediate filament-related com-
ponents and was originally identified as an autoantigen 
that reacted with serum from a patient with subepider-
mal blistering disease [1], [2]. Epiplakin is homologous to 
plectin and other members of the plakin family [1], [2]. 
Human epiplakin is a 552-kDa protein that is expressed 
in various epithelial tissues, i.e., epidermis, esophagus, 
outer root sheath of hair follicles and mucous epithelial 
cells [1], [2]. Studies by using an epiplakin-null mouse 
line showed that lacking epiplakin accelerates migra-
tion of epidermal keratinocytes in mice in vivo and also 
showed that this is also the case in outgrowth of keratino-
cytes from explanted skin tissue in  vitro, although the 
exact mechanism of the phenomena is to be revealed [3]. 
We reported that corneal epithelium, a non-keratinizing 
stratified squamous epithelium, also express epiplakin 
and its loss accelerates cell migration-dependent heal-
ing of the corneal epithelium in mice. The in vivo study 
showed reduced E-cadherin protein and mRNA in epi-
plakin -null corneal epithelium, although E-cadherin 
expression level is not altered in epidermis by the loss of 
epiplakin [4]. In the present study we investigated behav-
iors, i.e., cell migration and proliferation, of epiplakin-
knockdowned cultured corneal epithelial cell line and 
also examined the expression level of E-cadherin, kera-
tin 6 and vimentin, both members of intermediate fila-
ment involved in cell migration [5], in the cells, although 
decreased epiplakin expression does not solely explain 
the mechanism of cell migration acceleration in corneal 
epithelium.
Methods
Experimental protocols and the use of experimental 
mice were approved by the DNA Recombination Experi-
ment Committee and the Animal Care and Use Commit-
tee of Wakayama Medical University and conducted in 
accordance with the Association for Research in Vision 
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and Ophthalmology Statement for the Use of Animals in 
Ophthalmic and Vision Research.
Araki-Sasaki SV40-immortalized human corneal epi-
thelial cell line was obtained from RIKEN Laboratories, 
Tsukuba Japan. The phenotype of this cell line retains 
many of the properties identified in their primary cell 
counterpart [6]. They were grown to confluence in 
DMEM/F12 medium containing 200 U/ml of penicillin 
and streptomycin, 5 % FBS, 0.1 μg/ml cholera toxin, 5 μg/
ml insulin, and 10 ng/ml human epidermal growth factor 
(EGF).
Knockdown of epiplakin in a corneal epithelial cell 
line in vitro
Expression of epiplakin was knockdowned in Araki-
Sasaki cell line by employing a commercially available 
siRNA for epiplakin. The cells (2 ×  105) in each well of 
a six well plate in 2  ml antibiotic-free normal growth 
medium supplemented with 5 % fetal bovine serum. The 
cells were incubate at 37  °C under 5.0  % CO2 until the 
cells are 60–80  % confluent. Human epiplakin 1 siRNA 
(sc-77799, Santa Cruz Biotechnology, CA) or control 
siRNA (sc-37007, Santa Cruz Biotechnology) was trans-
fected for 6.0 h according to the protocol prepared by the 
manufacturer using siRNA Transfection Medium (sc-
36868, Santa Cruz Biotechnology). Cells without siRNA 
were also prepared (control). Normal growth medium 
(1.0 ml) containing 2 times the normal serum and anti-
biotics concentration (2× normal growth medium) was 
added to each well without removing the transfection 
mixture.
Cell migration by scratch assay
The cells were cultured for 72 h after siRNA transfection 
procedure. The medium was then replaced with fresh 1× 
normal growth medium and processed for scratch assay 
as previously reported. Two liner defects were produced 
by a silicone needle in monolayer of the cells in control 
culture and siRNA epiplakin knockdown culture. Six 
cultures were prepared for each condition. The closure 
of the defect was evaluated at two independent points 
in each defect under phase-contrast microscopy at every 
3 h until 30 h post-wounding. The width of the remaining 
defect was measured at four independent points at each 
time point and statistically analysed by Mann–Whitney 
U-test.
Cell proliferation assay
Araki-Sasaki cells were treated with epiplakin-siRNA or 
control siRNA as described above. Cells were seeded into 
wells of 96-well plates at the concentration of 1.0 ×104 
cells/100  l/well 72  h after siRNA treatment, and incu-
bated for 24 h. Twenty-six wells were prepared for each 
condition. Cell proliferation was assayed by using Alamar 
blue (Trek Diagnostic Systems, West Sussex, UK) accord-
ing to the manufacturer’s protocol [7]. After a wash with 
phosphate-buffered saline (PBS), 40 μL Alamar blue was 
diluted in culture medium (1:2).Thirty and sixty min 
later, the optical absorbance at 570 nm was measured at 
570 nm.
Western blotting for epiplakin, E‑cadherin, keratin 
6 and vimentin
The efficacy of knockdown of epiplakin protein expres-
sion was first evaluated by using western blotting 
with anti-epiplakin antibody (T-16, sc-87104, Santa 
Cruz:diluted 1:500) as previously reported [8]. Then pro-
tein expression of E-cadherin, keratin 6 and vimentin 
was assayed by western blotting as previously reported 
[8]. SDS-PAGE was done with the gel of Mini-PRO-
TEAN®  TGX™ Gel (Bio-Rad, #456-1096) under 200  V. 
The PVDF membrane was Immobilon-P Membrane, 
PVDF, 0.45 µm, 26 × 26 cm sheet.
(Merk Millipore Corporation, #IPVH304F0) and 
transfer the proteins under 5  V. Antibodies used were 
anti-E-cadherin antibody (G-10, sc-8426, Santa Cruz Bio-
technology, diluted 1:1000) and anti-kerarin 6 antibody 
(LHK6, sc-53260, Santa Cruz Biotechnology, diluted 
1:1000), and anti-vimentin antibody (C-20, sc-7557, 
Santa Cruz Biotechnology, diluted 1:1000).
Results and discussion
Present study was undertaken to uncover the roles of 
epiplakin in modulation of behaviors of cultured corneal 
epithelial cell line. Our previous in vivo study revealed 
that deletion of epiplakin gene in a mouse suppressed 
cell proliferation but accelerated migration-dependent 
wound healing in corneal epithelium in association 
with reduction of E-cadherin expression, although the 
mechanism was to be explored [4]. In the current study 
we employed siRNA knockdown for this purpose. Epi-
plakin siRNA nicely suppressed expression of epiplakin 
at the mRNA and protein levels as compared with cells 
with control siRNA transfection (Fig.  1). In scratch 
assay the time course of defect closure in cell culture 
indicated that epiplakin siRNA accelerated wound clo-
sure. As shown in Fig.  2, the width of the remaining 
defect was significantly smaller in epiplakin siRNA test 
culture as compared with control siRNA culture at 3 
and 9  h post-scratching. The in  vitro datum coincides 
our previous finding of cell migration promotion in cor-
neal epithelium of a epiplakin-null mouse. We and oth-
ers reports that p38 signal or c-Jun-N-terminal kinase 
modulates cell migration of corneal epithelium [9–11]. 
It is to be clarified whether the loss of epiplakin affects 
directly the signaling cascades that involves migration 
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of alteration of cytoskeletal structures might affect 
cell movement. On the other hand, Alamar blue assay 
showed that epiplakin siRNA knockdown significantly 
promoted cell proliferation as compared with control 
siRNA culture at 30 and 60  min (Fig.  3). Cell prolifer-
ation in in  vivo corneal epithelium was suppressed by 
the loss of epiplakin. The reason for this discrepancy is 
to be uncovered. Cell–cell contact molecules such as 
Wnt/b-catenin is reportedly involved in cell prolifera-
tion modulation [12]. It is to be examined if cell culture 
condition may affect cell adhesion mechanism related to 
cell proliferation.
Expression of each of E-cadherin, keratin 6 or vimen-
tin was suppressed by siRNA knockdown of epiplakin 
as compared with expression level of these compo-
nents in the cells with control siRNA as detected by 
using western blotting (Fig. 4). There is a possibility that 
suppression of expression of these three components 
might be included in the mechanism of promotion of 
migration of corneal epithelial cells. Decreased expres-
sion of E-cadherin was also observed in in vivo corneal 
epithelium of an epiplakin-null mouse [4]. A cell cul-
ture experiment previously showed that expression of 
a desmosome-related component affects E-cadherin 
Fig. 1 Epiplakin knockdown in cultured corneal epithelial cell line. Epiplakin knockdown by siRNA protocol nicely suppressed expression of epi-
plakin mRNA (a) and protein (b) as compared with control cells with control siRNA transfection
Fig. 2 Effects of knockdown of epiplakin in cell migration. A liner defect was produced in confluent culture of control and epiplakin-knockdowned 
cells and was allowed to closed by cell migration. The width of the remaining defect was significantly smaller in epiplakin siRNA test culture (red) 
as compared with control siRNA culture (blue) at 3 and 9 h post-scratching (a). Bar 500 m. Frame b shows the time course of defect closure in cell 
culture either with epiplakin siRNA or control siRNA
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expression; overexpression of desmoglein-3 decreases 
E-cadherin expression [13]. The loss of E-cadherin 
reportedly promotes the conversion of an epithelial cell 
to that of more migratory phenotype [14, 15]. Investi-
gations by using mutant mice suggest that desmosomal 
components perform modulating effects on cell prolif-
eration (positively or negatively) or differentiation. For 
example, keratinocyte proliferation initiated through 
downregulation of desmoplakin by RNA interfer-
ence in cell culture [16]. This might be also the case in 
in vivo condition; mice lacking desmocolin-1 exhibited 
epidermal hyperplasia, in association with supraba-
sal keratinocyte proliferation and alteration of expres-
sion pattern of other desmosomal components [17]. 
Overexpression of desmoglein-2 or -3 induces keratino-
cyte hyperproliferation in the epidermis suggesting that 
this desmoglein-2/3 positively regulate cell cycle pro-
gression [18, 19]. Plakoglobin participates in the regu-
lation of the c-Myc gene and highlights the importance 
and additional function of desmosomal constituent pro-
teins in the control of cell proliferation [20]. However, 
molecular mechanisms of modulation of cell prolifera-
tion in association with an alteration of expression level 
of a desmosomal component is still puzzling. Keratin 
6 is reportedly involved in migration of epithelial cell 
types including keratinocytes [3]. Decreased expres-
sion of this intermediate filament component might 
also be included the mechanism of migration accelera-
tion of corneal epithelial cells in  vitro. In the current 
in  vitro experiment expression of vimentin was also 
suppressed by epiplakin-knockdown. Although vimen-
tin-intermediate filament is also reportedly involved in 
cell migration [21], here decreased expression of vimen-
tin was associated with cell migration promotion. The 
cell biology underlying this phenomenon is also to be 
investigated.
Further study is to be conducted to uncover the mech-
anism of cell migration acceleration in the absence of 
epiplakin in  vivo and in  vitro in order to understand 
the biological mechanism underlying corneal epithelial 
wound healing.
Conclusions
SiRNA knockdown of epiplakin gene expression accel-
erated migration and proliferation of corneal epi-
thelial cell in cell culture. Decreased expression of 
E-cadherin, keratin 6 and vimentin might be included 
in the mechanisms of cell migration acceleration in 
the absence of epiplakin. The mechanism of cell pro-
liferation stimulation by epiplakin knockdown is to be 
investigated.
Fig. 3 Effect of epiplakin knockdown on cell proliferation. Con-
trol and epiplakin-knockdowned cells were grown in wells of 
96-well plates and Alamar blue dye was supplemented the culture 
medium. Relative absorbance of Alamar blue dye reaction in the 
medium was monitored to examine the activity of cell prolif-
eration. Epiplakin-siRNA knockdown significantly promoted cell 
proliferation as compared with control siRNA culture at 30 and 
60 min (Fig. 3). Evaluated as 95 % significant with the p value of 
1.07032763506866 × 10 (−13) (< 0.101,076) in the datum of 30 min, 
and p value = 1.87138814984332 × 10 (−8) (p < 0.028528) in the 
datum of 60 min
Fig. 4 Effect of epiplakin knockdown on protein expression of vimentin, E-cadherin and keratin 6. Control and epiplakin-knockdowned cells were 
grown in wells of 60-min culture dishes and the cells were collected for western blotting for vimentin, E-cadherin and keratin 6 as described in the 
manuscript. Expression of vimentin (a), E-cadherin (b) and keratin 6 (c) was suppressed by siRNA knockdown of epiplakin as compared with their 
expression level in cells with control siRNA transfection as detected by using western blotting
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